A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
Enrolling by invitation · Phase 2
Conditions studied: Melanoma
In brief
This study is researching the long-term effects of a combination of experimental drugs called fianlimab and cemiplimab. The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab in the study called R3767-ONC-1613 (NCT03005782). The aim of the current study is to see how safe and effective the study drugs are in a long-term follow-up. No study drug will be given during this study. Cancer status will be monitored, in addition to routine care. The study is also collecting information about general health status, and other treatments that may have been received since participation in study R3767-ONC-1613 (NCT03005782).
Key facts
- Study ID
- NCT06848088
- Run by
- Regeneron Pharmaceuticals
- People needed
- 48
- Starts
- 2025-04-14
- Expected to finish
- 2029-10-10
- Last updated by the study team
- 2026-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Angeles Clinic and Research Institute - West Los Angeles Office — Los Angeles, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
- University of Kansas Hospital — Westwood, Kansas, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- Cancer & Hematology Centers of Western Michigan — Grand Rapids, Michigan, United States
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
- Sarah Cannon Research Institute — Nashville, Tennessee, United States
- South Texas Oncology And Hematology — San Antonio, Texas, United States
- Virginia Cancer Care Specialist, PC — Fairfax, Virginia, United States
- St. Vincent's University Hospital — Dublin, Ireland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.